
Marillion Pharmaceuticals India Private Limited
About Marillion Pharmaceuticals India Private Limited
Data last updated:
Marillion Pharmaceuticals India Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Ventureast Trustee Company Private Limited. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 December 2005.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2005PTC048633.
The company had an authorised share capital of ₹9.85 Lakh and a paid-up capital of ₹9.66 Lakh. It was led by directors including Vishnu Kamalapuri and Zahed Subhan.
Its last annual general meeting (AGM) was held on 29 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at Hyderabad, Telangana.
The company has 1 deal on record (1 funding round), with disclosed funding of ₹14.41 Cr; the latest was in June 2007.
Company details
CIN history
Marillion Pharmaceuticals India has one previous CIN (Corporate Identification Number): U24239AP2005PTC048633. The current CIN is U24239TG2005PTC048633, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2005PTC048633 | Current |
| U24239AP2005PTC048633 | Previous |
Contact details
Marillion Pharmaceuticals India Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressVentureast Plaza Plot No 40 & 41 Sy.No.115/1 Financial District Nanakramguda Gachi, Bowli Post, Hyderabad, Telangana, India – 500032
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Marillion Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Marillion Pharmaceuticals India Private Limited
FY 2017 filings availableFinancial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Marillion Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Marillion Pharmaceuticals India Private Limited
Marillion Pharmaceuticals India has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishnu Kamalapuri | Director | 28 Jun 2015 | 11 Years 4 Months | As last reported |
| Zahed Subhan | Director | 29 Dec 2005 | 20 Years 10 Months | As last reported |
| Samiullah Shah Hussaini Syed | Director | 30 Sep 2014 | 12 Years 1 Months | As last reported |
Auditor
Marillion Pharmaceuticals India Private Limited is audited by R M M RAJU & CO for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R M M RAJU & CO | FY 2016 | 013362S |
Shareholding
The shareholding of Marillion Pharmaceuticals India Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Marillion Pharmaceuticals India Private Limited, buy the company report.
Deals & funding
Marillion Pharmaceuticals India Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹14.41 Cr; the latest was in June 2007.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2007 | Funding round | ₹14.41 Cr | Investors: VenturEast |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Marillion Pharmaceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Marillion Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Marillion Pharmaceuticals India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Marillion Pharmaceuticals India Private Limited has 8 board changes on record since 2005: 3 appointments and 5 cessations. The latest: Sreekanth Reddy Beeram ceased to be Additional Director on 12 Jul 2016.
Frequently asked questions
Marillion Pharmaceuticals India has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Marillion Pharmaceuticals India was a private limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 29 December 2005 and is registered under CIN U24239TG2005PTC048633. The company has been struck off by the Registrar of Companies and is no longer operational.
Marillion Pharmaceuticals India had 3 directors:
- Vishnu Kamalapuri - Director
- Zahed Subhan - Director
- Samiullah Shah Hussaini Syed - Director
The CIN (Corporate Identification Number) of Marillion Pharmaceuticals India is U24239TG2005PTC048633. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Marillion Pharmaceuticals India is at Ventureast Plaza Plot No 40 & 41 Sy.No.1151 Financial District Nanakramguda Gachi, Bowli Post, Hyderabad, Telangana, India – 500032.
Marillion Pharmaceuticals India was incorporated on 29 December 2005. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Marillion Pharmaceuticals India on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 29 September 2017. Year-wise statements from 2015 are in the company report.
Marillion Pharmaceuticals India operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Marillion Pharmaceuticals India has 1 deal on record (1 funding round), with disclosed funding of ₹14.41 Cr; the latest was in June 2007.
Sreekanth Reddy Beeram ceased to be Additional Director on 12 Jul 2016. Vishnu Kamalapuri ceased to be Additional Director on 30 Sep 2015. Ravi Babulal Jain ceased to be Director on 10 Aug 2015. Marillion Pharmaceuticals India has 8 board changes on record in total.

